 IRVINE, CA, Aug. 04, 2021 GLOBE NEWSWIRE -- Odyssey Group International, Inc. OTC: ODYY the Company or Odyssey, a technology and asset acquisition company focused on developing unique, life-saving medical products, today announced the successful completion of their Investigational New Drug IND enabling studies and submission of their Investigators Brochure IB for Ethics Committee review to begin Phase 1 clinical trials for the first in-human treatment of concussion. 